POCP Blog

How Stakeholders are Affected by FDA’s New Naming Convention for Biologics and Biosimilars

By Pooja Babbrah, Senior Consultant Stakeholders across the industry are debating potential costs and burden associated with implementing the new, nonproprietary naming convention for biologics and biosimilars. Requirements for the …

EHRs Offer Ready-Made Tools for Population Health Management

By Michael Burger, Senior Consultant Providers need tools for population health management (PHM) for reimbursement as well as reporting on metrics for related activities and quality improvement. While most physicians …

Medication Non-Adherence: Is There an App for That?

By Pooja Babbrah, Senior Consultant  Getting patients to adhere to their medication regimen is a growing problem—and solutions are being sought. The reasons are compelling. Non-adherence to prescribed medications results in $100 to $300 billion in avoidable healthcare costs. A significant portion of …

States Step Up Focus on PDMP Utilization to Address Opioid Crisis

By Connie Sinclair, Senior Consultant As the opiate crisis receives ongoing national attention, state policymakers and legislators continue to chip away at the problem with new laws and rules governing …

Do We Need a National Patient Identifier?

By Michael Burger, Practice Lead, EHRs and EDI Interoperability continues to be top of mind for industry pundits and the Office of the National Coordinator for Health Information Technology (ONC). …

In Memory of Pharmacy HIT Visionary James D. Lang

This past Saturday there was a memorial service for James D. Lang, PharmD, Vice President of Pharmacy Services at Blue Cross Blue Shield of Michigan (BCBSM), who passed away unexpectedly …

Using Real-World Data to Power Population Health Analytics

Insights for Life Sciences Companies As the quality of payers’ data on their members’ health outcomes gets better with each passing day, achieving measurable quality targets is increasingly becoming the basis for …

Electronic Prior Authorization Being Brought into Pharmacists’ Workflow

By Jocelyn Keegan, Senior Consultant With recent legislative changes and maturity in the industry, pharmacists will soon be enabled to electronically initiate and handle pre-approval—or prior authorization (PA) — directly …

Improving Care Quality using ePrescribing: CancelRx

Electronic prescribing (ePrescribing) is ubiquitous, but there is still room for improvement. Many, including RAND researchers, put the CancelRx transaction at the top of the list, because of its implications for …

How Pharmaceutical Companies Could be Affected by the AMA’s Prior Authorization and Utilization Management Reform Proposal

Prior authorization (PA) for medications, devices and services is viewed as a valuable utilization management tool by payers but is a long-standing pain point for providers, pharmacists and the pharmaceutical …